Submitted by Anonymous (not verified) on 25 July 2025 - 10:43
Human medicines European public assessment report (EPAR): Xoterna Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 18/09/2013, Revision: 18, Status: Authorised
Source: